JOURNAL OF PSYCHOACTIVE DRUGS

Scope & Guideline

Navigating the Therapeutic Potentials of Psychoactive Agents

Introduction

Welcome to the JOURNAL OF PSYCHOACTIVE DRUGS information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of JOURNAL OF PSYCHOACTIVE DRUGS, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0279-1072
PublisherROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1967 to 1972, from 1974 to 2024
AbbreviationJ PSYCHOACTIVE DRUGS / J. Psychoact. Drugs
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND

Aims and Scopes

The 'Journal of Psychoactive Drugs' focuses on a multidisciplinary approach to the study of psychoactive substances and their effects, encompassing various aspects of drug use, including health, psychology, sociology, and policy. The journal aims to advance the understanding of psychoactive drugs through empirical research, theoretical frameworks, and reviews that highlight the complexities surrounding substance use and its societal implications.
  1. Psychedelic Research and Therapeutics:
    The journal emphasizes the therapeutic potential of psychedelics, exploring their use in treating mental health disorders, substance use disorders, and other psychological conditions.
  2. Substance Use Epidemiology:
    Research focusing on the prevalence, patterns, and correlates of psychoactive substance use across different populations, including marginalized and vulnerable groups.
  3. Cultural and Social Contexts of Drug Use:
    Investigates the cultural, social, and community aspects of drug use, including stigma, identity, and the impact of drug policies on different populations.
  4. Harm Reduction Strategies:
    Promotes research on harm reduction approaches, assessing their effectiveness and implementation in various settings, particularly for high-risk substance users.
  5. Psychosocial Factors and Substance Use:
    Examines the psychological, social, and behavioral factors that influence substance use, including coping strategies, mental health comorbidities, and recovery processes.
The 'Journal of Psychoactive Drugs' has seen a significant evolution in its research themes, with certain topics gaining increased attention in recent publications. This section identifies emerging themes that are shaping the journal's current focus, reflecting contemporary issues and innovative research directions.
  1. Psychedelic-Assisted Therapies:
    There is a growing body of research investigating the applications of psychedelics in therapeutic settings, especially concerning mental health disorders such as depression, PTSD, and anxiety.
  2. Impact of Legalization and Policy Change:
    Emerging studies focus on the implications of drug legalization and policy changes, particularly surrounding cannabis and the societal impacts of these shifts.
  3. Intersection of Substance Use and Mental Health:
    Research increasingly explores the interplay between substance use and mental health, highlighting comorbidities and integrated treatment approaches.
  4. Community-Based Drug Interventions:
    There is an increasing emphasis on community-level interventions and harm reduction strategies that consider local cultural contexts and community health.
  5. Microdosing Practices and Effects:
    The phenomenon of psychedelic microdosing is gaining traction, with studies examining its effects on creativity, mental health, and overall well-being.

Declining or Waning

While the journal continues to publish a broad range of topics, certain themes appear to be declining in prominence over recent years. This section highlights the areas that have seen reduced focus or interest among researchers, indicating potential shifts in the field's priorities or emerging trends overshadowing these topics.
  1. Traditional Drug Use Studies:
    There is a noticeable decrease in studies focused solely on traditional or historical uses of substances without a contemporary context, reflecting a shift towards more applied and intervention-focused research.
  2. Basic Pharmacological Studies:
    Research centered on basic pharmacology of psychoactive substances, such as isolated pharmacodynamics or pharmacokinetics, has waned in favor of studies that address clinical implications and real-world applications.
  3. General Attitudes Towards Drug Use:
    Papers exploring general public attitudes towards drug use, without a specific focus on therapeutic or harm reduction implications, seem to be less frequently published.
  4. Non-Psychoactive Substances:
    Research on substances that are not considered psychoactive (e.g., certain dietary supplements or non-drug interventions) has become less common, as the journal's focus has shifted more towards psychoactive drugs.

Similar Journals

AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

Illuminating the Pathways of Recovery and Treatment
Publisher: TAYLOR & FRANCIS INCISSN: 0095-2990Frequency: 6 issues/year

American Journal of Drug and Alcohol Abuse is a highly regarded publication in the field of substance abuse research, published by Taylor & Francis Inc. With its inception in 1974, this journal has become an essential resource for scholars and practitioners interested in clinical psychology, psychiatry, and the multifaceted issues surrounding drug and alcohol use. It holds a notable Q2 ranking in Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health, emphasizing its impact and relevance in these domains. The journal's 2023 Scopus rankings further highlight its standing, placing it in the top quartile of publications with established readership and citation metrics. Researchers and students can benefit from its comprehensive articles that delve into the complexities of substance use, treatment methodologies, and the socio-psychological underpinnings of addiction. Whether you seek to access cutting-edge studies or contribute to ongoing discourse in the field, the American Journal of Drug and Alcohol Abuse serves as a vital hub for knowledge dissemination and scholarly engagement.

Journal of Addictions Nursing

Leading the Charge in Addiction Treatment Knowledge
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1088-4602Frequency: 4 issues/year

The Journal of Addictions Nursing, published by Lippincott Williams & Wilkins, serves as a pivotal resource in the field of psychiatric and mental health nursing. With an ISSN of 1088-4602 and an E-ISSN of 1548-7148, this esteemed journal has been dedicated to advancing the knowledge and practice of addiction nursing since its inception in 1989. As of 2023, it ranks in the Q3 category of psychiatry and mental health, highlighting its significance amidst its peers. The journal provides a platform for the dissemination of original research, reviews, and clinical practices that address the complexities of addiction treatment and care. While it currently does not offer open access options, its valuable insights are accessible to practitioners and researchers committed to improving patient outcomes. With content spanning from 1989 to 2024, the journal continues to shape the discourse in this vital area of nursing, making it an essential read for professionals and scholars aiming to stay at the forefront of addiction nursing and intervention strategies.

Alkoholizm i Narkomania-Alcoholism and Drug Addiction

Advancing knowledge on addiction's complexities.
Publisher: INST PSYCHIATRY & NEUROLOGY, DEPT STUDIES ALCOHOLISMISSN: 0867-4361Frequency: 4 issues/year

Alkoholizm i Narkomania - Alcoholism and Drug Addiction is a prominent peer-reviewed journal published by the Institute of Psychiatry and Neurology, Department of Studies on Alcoholism in Warsaw, Poland. Renowned for its commitment to advancing the fields of addiction research and mental health, this journal disseminates critical findings regarding the prevention, treatment, and societal implications of alcoholism and drug addiction. Since becoming Open Access in 2017, it ensures that researchers, professionals, and students from across the globe have unrestricted access to valuable resources and emerging studies within this vital area of public health. The journal emphasizes innovative methodologies and interdisciplinary approaches, inviting contributions that explore the complex interplay of psychological, social, and biological factors influencing addiction. By fostering a collaborative and inclusive scholarly community, Alkoholizm i Narkomania aims to contribute significantly to the understanding and resolution of addiction-related challenges worldwide.

Journal of Studies on Alcohol and Drugs

Illuminating the complexities of alcohol and drug research.
Publisher: ALCOHOL RES DOCUMENTATION INC CENT ALCOHOL STUD RUTGERS UNIVISSN: 1937-1888Frequency: 6 issues/year

The Journal of Studies on Alcohol and Drugs is a premier academic journal dedicated to advancing the understanding of alcohol and drug use, its effects, and its societal implications. Published by ALCOHOL RES DOCUMENTATION INC at the Center for Alcohol Studies, Rutgers University, this journal features comprehensive research that spans the disciplines of health, psychiatry, mental health, and toxicology. With its Q1 ranking in Health (Social Science) and Q2 ranking in Psychiatry and Mental Health, the journal plays a vital role in disseminating high-impact research that informs policy, prevention, and treatment strategies in addiction and substance use. The journal contributes significantly to the field, as evidenced by its solid Scopus rankings and engagement with contemporary issues, making it an essential resource for researchers, practitioners, and students. Although it does not offer open access, the journal's commitment to rigorous peer review and scholarship ensures that it remains at the forefront of research on alcohol and drugs through its converged publication timeline from 2007 to 2024.

Journal of Dual Diagnosis

Exploring the complexities of dual diagnosis.
Publisher: ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTDISSN: 1550-4263Frequency: 4 issues/year

The Journal of Dual Diagnosis, published by Routledge Journals, Taylor & Francis Ltd, is a leading interdisciplinary platform dedicated to the critical study of co-occurring mental health and substance use disorders. With its ISSN 1550-4263 and E-ISSN 1550-4271, this esteemed journal has been at the forefront of advancing research and clinical practice since its inception in 2004, and continues to serve as a vital resource until 2024. Ranked in the second quartile (Q2) in Psychiatry and Mental Health and positioned at the 64th percentile in the Scopus rankings, it emphasizes the importance of integrating care across various domains of health. Although not open access, it offers a wealth of peer-reviewed articles, case studies, and reviews suitable for researchers, practitioners, and students alike, aiming to enhance our understanding and treatment of dual diagnosis. The journal's commitment to addressing the complexities of dual disorders not only informs research but also shapes policy and clinical guidelines, making it an essential read for anyone involved in these critical areas of mental health.

JOURNAL OF DRUG EDUCATION

Illuminating Paths to Informed Policy-Making.
Publisher: SAGE PUBLICATIONS INCISSN: 0047-2379Frequency: 4 issues/year

JOURNAL OF DRUG EDUCATION, published by SAGE Publications Inc, serves as a vital platform for disseminating research and scholarly articles in the fields of health education, medicine, and mental health, focusing on drug-related issues. With its history dating back to 1972 and an ongoing publication cycle through 2024, the journal aims to enrich professional practice and inform policy-making through rigorous research. Although it does not currently operate under an Open Access model, the journal holds respectable rankings, finding itself in the third quartile across multiple categories including Health (Social Science), Medicine (Miscellaneous), Psychiatry and Mental Health, and Public Health, Environmental and Occupational Health, as per the 2023 metrics. This evaluation signifies its contribution to the discourse surrounding drug education and public health albeit within a competitive landscape. Scholars, researchers, and practitioners in the field are encouraged to engage with and contribute to this important dialogue addressing drug-related challenges in contemporary society.

DRUGS-EDUCATION PREVENTION AND POLICY

Fostering impactful research in drug prevention and education.
Publisher: TAYLOR & FRANCIS LTDISSN: 0968-7637Frequency: 6 issues/year

DRUGS-EDUCATION PREVENTION AND POLICY is a premier scholarly journal published by Taylor & Francis Ltd, focusing on the critical intersection of drug education, prevention strategies, and policy formulation. Established in 1994 and continuing through its converged years into 2024, this journal holds significant relevance within the health and social sciences fields, with commendable standings reflected in its 2023 category quartile rankings of Q2 in both Health (Social Science) and Medicine (Miscellaneous). With an impact ranking that places it in the 73rd and 67th percentiles respectively, it serves as an influential platform for researchers, professionals, and students to disseminate innovative research, case studies, and policy analyses. Those interested in the complexities of drug-related issues are encouraged to explore the insights provided by this journal, contributing to the ongoing discourse in effective prevention and education practices in the context of drug use and its social implications. Although access to articles is not open, the wealth of knowledge presented is invaluable for academia and policy formulation alike.

Substance Abuse

Leading the dialogue on substance abuse research.
Publisher: SAGE PUBLICATIONS INCISSN: 0889-7077Frequency: 4 issues/year

Substance Abuse is a premier scholarly journal published by SAGE Publications Inc, dedicated to advancing the understanding and treatment of substance use disorders. With an established presence from 1995 to 2023, the journal boasts an impressive Q1 ranking in both Medicine (miscellaneous) and Psychiatry and Mental Health, positioning it among the top tier of academic publications in these fields. Researchers and professionals will find its articles, which are grounded in rigorous empirical studies and innovative interventions, essential for addressing the complex and multifaceted nature of substance abuse. Although not an open access publication, Substance Abuse maintains a commitment to sharing valuable insights and findings, making it a vital resource for those looking to enhance their knowledge and practice. Located in Thousand Oaks, CA, this journal serves as a critical forum for international dialogue and research dissemination, ensuring that current trends and challenges in substance use are thoughtfully examined and discussed within the academic community.

SUBSTANCE USE & MISUSE

Unraveling the intricacies of substance use to inform policy and practice.
Publisher: TAYLOR & FRANCIS INCISSN: 1082-6084Frequency: 14 issues/year

SUBSTANCE USE & MISUSE, published by Taylor & Francis Inc, is an esteemed academic journal dedicated to the multifaceted study of substance use and its implications on health and society. With a notable impact factor and categorized in the Q2 quartile across multiple fields—including Health (Social Science), Medicine (Miscellaneous), Psychiatry and Mental Health, as well as Public Health—this journal serves as an essential platform for researchers, professionals, and students alike. Spanning from 1966 to 2024, it provides a rich archive of peer-reviewed articles that explore current trends, innovative research, and evidence-based practices in the management and understanding of substance use. The journal offers various access options, catering to the diverse needs of its audience and affirming its commitment to fostering scholarly discourse in the United Kingdom and beyond. By engaging with this journal, readers can enhance their understanding of the complexities surrounding substance use, making it a crucial resource for advancing knowledge and informing policy in this critical area of public health.

DRUG AND ALCOHOL REVIEW

Bridging disciplines to tackle addiction challenges.
Publisher: WILEYISSN: 0959-5236Frequency: 6 issues/year

DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.